Biotech Values

[zipjet]

>>IMO paying executives' tax liabilities is much worse than inversion itself - I don't have problem with inversion in general term because at least you can argue inversion is for ALL shareholders.

I think I agree on that one. While shareholder-employees are different than just shareholders and there is some rationale for treating them differently, I suspect that companies should not pick up the tax caused by an inversion.

That said, I am mindful that if the company did not pick up the tax, the event would create a window for key employees to move to another company. So again this is not without a trade-off.

I suspect the answer to this decision comes down to executive self-interest tilting the balance toward reimbursement.

ij